Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DRUG DELIVERY DEVICE
Document Type and Number:
WIPO Patent Application WO/2017/177094
Kind Code:
A3
Abstract:
Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device includes a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector defines a sterile fluid flowpath between the container and the insertion mechanism. A cannula initially disposed about the needle is included.

Inventors:
GIBSON SCOTT R (US)
MOBERG SHELDON B (US)
TAHA BASEL HASAN (US)
BOYAVAL MARGAUX FRANCES (US)
DESTEFANO MARK A (US)
LAURENCE LAWTON (US)
LOVE JOHN C (US)
HANSON IAN B (US)
BENTE PAUL F (US)
CLEMENTE MATTHEW J (US)
UBACH ANTONIO (US)
RAMASWAMY RAJAN (US)
CODD DANIEL S (US)
BEAVER SCOTT (US)
BOKELMAN KEVIN L (US)
DARDANI IAN P (US)
O'CONNOR SEAN M (US)
FELDMAN DANIELLE (US)
Application Number:
PCT/US2017/026524
Publication Date:
November 16, 2017
Filing Date:
April 07, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AMGEN INC (US)
International Classes:
A61M5/142; A61M5/145; A61M5/158; A61M5/315
Domestic Patent References:
WO2011133823A12011-10-27
Foreign References:
US20110066012A12011-03-17
US20150217045A12015-08-06
US8282601B22012-10-09
Attorney, Agent or Firm:
CHAVKA, Daniel, T. (US)
Download PDF: